tirzepatide o semaglutide cual es mejor Semaglutida y tirzepatida se consolidan como fármacos de elección contra la obesidad Tirzepatida. Llega al país un

View on PubMed Retatrutide: A Triple Incretin Receptor Agonist for Obesity Management Expert review characterising retatrutide as a first-in-class GIP, GLP-1, and glucagon triple receptor agonist, detailing its mechanism of action, pharmacokinetics, and the clinical significance of adding glucagon receptor agonism to produce superior weight loss to dual agonists (Expert Opin Investig Drugs, 2023)

Developed in collaboration with argenx, this work highlights the potential of human ex vivo models to improve formulation safety assessment while helping reduce reliance on animal testing

PlexusDx recommends flexibility over restrictionfocus on feeling good rather than counting calories

[DOI] [PMC free article] [PubMed] [Google Scholar] Haddy FJ, Scott JB